Ma, Hongming http://orcid.org/0000-0001-5105-1332
Adams, Lucas J. http://orcid.org/0000-0002-1724-8120
Raju, Saravanan
Sariol, Alan
Kafai, Natasha M.
Janova, Hana
Klimstra, William B.
Fremont, Daved H. http://orcid.org/0000-0002-8544-2689
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI141436, U19 AI142790)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
United States Department of Defense | Defense Threat Reduction Agency (MCDC2103-01, MCDC2103-01)
Article History
Received: 19 July 2023
Accepted: 19 December 2023
First Online: 4 January 2024
Competing interests
: M.S.D. is a consultant on the Scientific Advisory Board for Inbios, Ocugen, Vir Biotechnology, Topspin Therapeutics, and Moderna. The Diamond Laboratory has received unrelated funding support in sponsored research agreements from Emergent BioSolutions, Moderna, and Vir Biotechnology. D.H.F. is a founder of Courier Therapeutics and has received unrelated funding support from Emergent BioSolutions and Mallinckrodt Pharmaceuticals. All other authors declare no competing interests.